DERNIÈRE MISE À JOUR DU SITE: January 15th, 2026
Outcomes of Percutaneous Coronary Intervention for Cardiogenic Shock After Coronary Artery Bypass Graft The American Journal of Cardiology 258 (2026) 346â 351 Contents lists available at ScienceDirect The American Journal of Cardiology journal homepage: www.elsevier.com/locate/ajc
Prenatal diagnosis of complete heart block: How many times will my child’s pacemaker be changed? 20 year retrospective study 05 â
Prenatal diagnosis of complete heart block: How many times will my child’s pacemaker be changed? 20 year retrospective study 05 â
/home/gnm/gcebuket/archivesrobot/phaseIV/2025/10/21/taylor_local/ierd20_ierd20.ahead-of-print_2561242_20251021075115_49367737_17434440.2025.2561242/Full_text_PDF/ierd20_ierd20.ahead-of-print_2561242_20251021075115_49367737_17434440.2025.2561242 EXPERT REVIEW OF MEDICAL DEVICES https://doi.org/10.1080/17434440.2025.2561242 DEVICE PROFILE Device profile of the EVOQUE Eos system for transcatheter mitral valve replacement: a brief narrative review Michail Penteris a and Konstantinos Lampropoulosb,c aDepartment of Medicine, Democritus University of Thrace, Alexandroupolis, Greece; bSchool of Medicine, European University Cyprus, Nicosia, Cyprus; cDepartment of Cardiology, Euroclinic of Athens, Athens, Greece ABSTRACT ARTICLE HISTORY Introduction: Severe mitral regurgitation (MR) poses significant therapeutic challenges, especially in Received 8 July 2025 patients at high surgical risk or unsuitable for transcatheter edge-to-edge repair (TEER). Transcatheter Accepted 10 September 2025
609 ARTICLES DISPONIBLES
Abstract Tricuspid regurgitation is a common valve disease with high incidence and poor prognosis. For elderly patients and those with
Abstract Background The Hydra CE study revealed 1‐year favorable efficacy of TAVR, showing a large effective orifice area (EOA), low
Abstract Aims Mitral stenosis (MS) occasionally coexists with aortic stenosis (AS). Limited data are available regarding the functional class and
